# XALKORI
> **NDA217581** · New Drug Application · Sponsor: PF PRISM CV · Approved 2023-09-07
## Drug
- **FDA Application Number:** NDA217581
- **Application type:** New Drug Application
- **Brand name:** XALKORI
- **Generic name:** CRIZOTINIB
- **Active ingredients:** CRIZOTINIB
- **Dosage form:** CAPSULE, PELLETS
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** PF PRISM CV
- **Manufacturer:** Pfizer Laboratories Div Pfizer Inc
- **First approval:** 2023-09-07
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217581)
---
*MORVS · CC0 1.0*